Tamron (7740) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales rose 32.2% year-over-year to ¥68,456 million for 3Q FY2024, with operating income up 64.3% and net income up 53.7% year-over-year.
Surpassed previous full-year record for operating income and met first-year targets of the new medium-term plan ahead of schedule.
Comprehensive income increased 23.3% year-over-year to ¥13,119 million.
Implemented shareholder-friendly actions: ¥2 billion treasury share repurchase, 2-for-1 stock split, and increased dividend forecasts.
Financial highlights
Gross profit margin improved to 45.5% (+0.7pt YoY); operating income margin rose to 24.4% (+4.7pt YoY).
Gross profit increased from ¥23,218 million to ¥31,144 million year-over-year.
EPS (basic) was ¥295.77, up from ¥190.29, reflecting a 2-for-1 stock split effective July 1, 2024.
Total assets grew to ¥96,412 million from ¥87,062 million at FY2023-end; net assets rose to ¥77,539 million.
Favorable foreign exchange rates contributed ¥4.85 billion to net sales and ¥1.34 billion to operating income for 1Q–3Q.
Outlook and guidance
Full-year FY2024 guidance revised upward: net sales ¥89,000 million (+24.6% YoY), operating income ¥19,600 million (+44.0% YoY), net income ¥14,430 million (+33.5% YoY).
Net profit per share forecast at ¥349.28 for FY2024, post stock split.
Expects to exceed first-year targets of the "Value Creation 26" medium-term plan in sales, operating income, and ROE.
Segment forecasts: double-digit sales growth in Photographic Products, 25% sales growth in Surveillance & FA Lenses, and 1.3x sales growth in Mobility & Healthcare Products.
Latest events from Tamron
- FY2025 profits fell, but Q4 rebounded and FY2026 forecasts renewed growth and new launches.7740
Q4 20256 Feb 2026 - Sales and profit fell, but full-year guidance projects modest growth and stable dividends.7740
Q3 20256 Nov 2025 - Profits fell YoY in 1H FY2025, but cost controls drove outperformance versus forecasts.7740
Q2 20257 Aug 2025 - Sales and profits soared, with FY2024 outlook and dividends revised upward post stock split.7740
Q2 202413 Jun 2025 - Sales and profits fell in 1Q FY2025, with guidance signaling continued challenges.7740
Q1 20256 Jun 2025 - Record sales, double-digit profit growth, and new stock splits signal strong momentum.7740
Q4 20245 Jun 2025